← Back
Data updated: Mar 10, 2026
PF PRISM CV
OncologyInfectious DiseaseDermatology
PF PRISM CV is a major pharmaceutical company focused on Oncology, Infectious Disease, Dermatology. Key products include XELJANZ.
1999
Since
11
Drugs
-
Trials
23
Approved (2yr)
Key Drugs
Recent Activity
VFEND 2026-02-19
Labeling
VFEND 2026-02-19
Labeling
VFEND 2026-02-19
Labeling
VFEND 2026-01-28
Labeling
VFEND 2026-01-28
Labeling
VFEND 2026-01-28
Labeling
XELJANZ 2025-10-16
Efficacy
XELJANZ 2025-10-16
Efficacy
CHANTIX 2025-06-24
Manufacturing (CMC)
TYGACIL 2025-03-31
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Oncology 50%
3 drugs
Infectious Disease 33%
2 drugs
Dermatology 17%
1 drugs
Pipeline Strength Pro
Loading...
Competitors Pro
Pfizer big-pharma
Oncology, Infectious Disease, Dermatology
Baxter specialty
Infectious Disease, Oncology, Dermatology
COSETTE other
Dermatology, Infectious Disease, Oncology
KING PHARMS LLC big-pharma
Infectious Disease, Dermatology, Oncology
FOUGERA PHARMS other
Dermatology, Infectious Disease, Oncology